Scribe Therapeutics (SCTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 38 70 sessions, July 24, 2026 to October 30, 2026
- Largest daily move
- +27.9% close of August 18, 2026
- 1-month change
- -16.2% closing prices, September 30, 2026 to October 30, 2026
Company Description
Scribe Therapeutics (NASDAQ: SCTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $288.7M.
SCTX has declined 16.2% over the past month. The last closing price was $15.42.
This page collects what Stock Titan holds for SCTX, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
Scribe Therapeutics (SCTX) closed at $15.42 on October 30, 2026. Over the past month, the price has lost 16.2%.
SCTX Metrics & Rankings
Price returns through October 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Scribe Therapeutics has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, conferences, IPO, private placement, offering. View all SCTX news →
SEC Filings
Scribe Therapeutics has filed 10 recent SEC filings, including 6 Form 4, 2 Form SCHEDULE 13D, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SCTX SEC filings →
Financial Highlights
Upcoming Events
Initial SAD data
Scribe Therapeutics has 1 upcoming scheduled event. The next event, "Initial SAD data", is expected in H1 2027. Investors can track these dates to stay informed about potential catalysts that may affect the SCTX stock price.
Short Interest History
Short interest in Scribe Therapeutics (SCTX) currently stands at 1.1 million shares, down 54.7% from the previous reporting period, representing 7.2% of the float. Since July 2026, short interest has increased by 325.2%.
Days to Cover History
Days to cover for Scribe Therapeutics (SCTX) currently stands at 2.4 days, down 34.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since July 2026, the figure has increased by 76.1%. Across the settlements charted above, it has ranged from 1.3 to 4.6 days.
SCTX Company Profile & Sector Positioning
Scribe Therapeutics (SCTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing SCTX often look at related companies in the same sector, including Eikon Therapeutics, Inc. (EIKN), Fulcrum Therapeutics, Inc. (FULC), Vicore Pharma Holding AB (VCRE), Lyell Immunopharma, Inc. (LYEL), and Rocket Pharmaceuticals, Inc. (RCKT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SCTX's relative position within its industry.